Cargando…

Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis

Intravenous leiomyomatosis (IVL) is an unusual uterine smooth muscle proliferation that can be associated with aggressive clinical behavior despite a histologically benign appearance. It has some overlapping molecular characteristics with both uterine leiomyoma and leiomyosarcoma based on limited ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordulu, Zehra, Chai, Hongyan, Peng, Gang, McDonald, Anna G, De Nictolis, Michele, Garcia-Fernandez, Eugenia, Hardisson, David, Prat, Jaime, Li, Peining, Hui, Pei, Oliva, Esther, Buza, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483566/
https://www.ncbi.nlm.nih.gov/pubmed/32341498
http://dx.doi.org/10.1038/s41379-020-0546-8
_version_ 1783580942171897856
author Ordulu, Zehra
Chai, Hongyan
Peng, Gang
McDonald, Anna G
De Nictolis, Michele
Garcia-Fernandez, Eugenia
Hardisson, David
Prat, Jaime
Li, Peining
Hui, Pei
Oliva, Esther
Buza, Natalia
author_facet Ordulu, Zehra
Chai, Hongyan
Peng, Gang
McDonald, Anna G
De Nictolis, Michele
Garcia-Fernandez, Eugenia
Hardisson, David
Prat, Jaime
Li, Peining
Hui, Pei
Oliva, Esther
Buza, Natalia
author_sort Ordulu, Zehra
collection PubMed
description Intravenous leiomyomatosis (IVL) is an unusual uterine smooth muscle proliferation that can be associated with aggressive clinical behavior despite a histologically benign appearance. It has some overlapping molecular characteristics with both uterine leiomyoma and leiomyosarcoma based on limited genetic data. In this study, we assessed the clinical and morphological characteristics of 28 IVL and their correlation with molecular features and protein expression, using array comparative genomic hybridization (aCGH) and Cyclin D1, p16, phosphorylated-Rb, SMARCB1, SOX10, CAIX, SDHB and FH immunohistochemistry. The most common morphologies were cellular (n=15), usual (n=11) and vascular (n=5; including 3 cellular IVL showing both vascular and cellular features). Among the immunohistochemical findings, the most striking was that all IVL showed differential expression of either p16 or Cyclin D1 in comparison to surrounding non-neoplastic tissue. Cytoplasmic phosphorylated-Rb was present in all but one IVL with hyalinization. SMARCB1, FH and SDHB were retained; S0X10 and CAIX were not expressed. The most common genetic alterations involved 1p (39%), 22q (36%), 2q (29%), 1q (25%), 13q (21%) and 14q (21%). Hierarchical clustering analysis of recurrent aberrations revealed 3 molecular groups: Group 1 (29%) and 2 (18%) with associated del(22q) and group 3 (18%) with del(10q). The remaining IVL had non-specific or no alterations by aCGH. Genomic index scores were calculated for all cases and showed no significant difference between the 14 IVL associated with aggressive clinical behavior (extrauterine extension or recurrence) and those without (median scores 5.15 vs 3.5). Among the 5 IVL associated with recurrence, 4 had a vascular morphology and 3 had alterations of 8q. Recurrent chromosome alterations detected herein overlap with those observed in the spectrum of uterine smooth muscle tumors and involve genes implicated in mesenchymal tumors at different sites with distinct morphological features.
format Online
Article
Text
id pubmed-7483566
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-74835662020-10-27 Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis Ordulu, Zehra Chai, Hongyan Peng, Gang McDonald, Anna G De Nictolis, Michele Garcia-Fernandez, Eugenia Hardisson, David Prat, Jaime Li, Peining Hui, Pei Oliva, Esther Buza, Natalia Mod Pathol Article Intravenous leiomyomatosis (IVL) is an unusual uterine smooth muscle proliferation that can be associated with aggressive clinical behavior despite a histologically benign appearance. It has some overlapping molecular characteristics with both uterine leiomyoma and leiomyosarcoma based on limited genetic data. In this study, we assessed the clinical and morphological characteristics of 28 IVL and their correlation with molecular features and protein expression, using array comparative genomic hybridization (aCGH) and Cyclin D1, p16, phosphorylated-Rb, SMARCB1, SOX10, CAIX, SDHB and FH immunohistochemistry. The most common morphologies were cellular (n=15), usual (n=11) and vascular (n=5; including 3 cellular IVL showing both vascular and cellular features). Among the immunohistochemical findings, the most striking was that all IVL showed differential expression of either p16 or Cyclin D1 in comparison to surrounding non-neoplastic tissue. Cytoplasmic phosphorylated-Rb was present in all but one IVL with hyalinization. SMARCB1, FH and SDHB were retained; S0X10 and CAIX were not expressed. The most common genetic alterations involved 1p (39%), 22q (36%), 2q (29%), 1q (25%), 13q (21%) and 14q (21%). Hierarchical clustering analysis of recurrent aberrations revealed 3 molecular groups: Group 1 (29%) and 2 (18%) with associated del(22q) and group 3 (18%) with del(10q). The remaining IVL had non-specific or no alterations by aCGH. Genomic index scores were calculated for all cases and showed no significant difference between the 14 IVL associated with aggressive clinical behavior (extrauterine extension or recurrence) and those without (median scores 5.15 vs 3.5). Among the 5 IVL associated with recurrence, 4 had a vascular morphology and 3 had alterations of 8q. Recurrent chromosome alterations detected herein overlap with those observed in the spectrum of uterine smooth muscle tumors and involve genes implicated in mesenchymal tumors at different sites with distinct morphological features. 2020-04-27 2020-09 /pmc/articles/PMC7483566/ /pubmed/32341498 http://dx.doi.org/10.1038/s41379-020-0546-8 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Ordulu, Zehra
Chai, Hongyan
Peng, Gang
McDonald, Anna G
De Nictolis, Michele
Garcia-Fernandez, Eugenia
Hardisson, David
Prat, Jaime
Li, Peining
Hui, Pei
Oliva, Esther
Buza, Natalia
Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis
title Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis
title_full Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis
title_fullStr Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis
title_full_unstemmed Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis
title_short Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis
title_sort molecular and clinicopathologic characterization of intravenous leiomyomatosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483566/
https://www.ncbi.nlm.nih.gov/pubmed/32341498
http://dx.doi.org/10.1038/s41379-020-0546-8
work_keys_str_mv AT orduluzehra molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT chaihongyan molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT penggang molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT mcdonaldannag molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT denictolismichele molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT garciafernandezeugenia molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT hardissondavid molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT pratjaime molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT lipeining molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT huipei molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT olivaesther molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis
AT buzanatalia molecularandclinicopathologiccharacterizationofintravenousleiomyomatosis